Giovanna Petrucci
Giovanna Petrucci is Associate Professor of Pharmacology at UniCamillus University, Rome. She graduated with honors in Natural Sciences at “La Sapienza” University of Rome and obtained her PhD in Pathophysiology and Pharmacology of Hemostasis and Thrombosis at the Catholic University of the Sacred Heart, where she served as a tenured researcher in Pharmacology until 2025, combining teaching activities with a strong research focus on cardiovascular pharmacology.
Her research interest lie primarily in cardiovascular pharmacology, with specific expertise in platelet biology, thromboxane biosynthesis, and the role of oxidative stress in thrombotic and inflammatory disorders. She has extensively investigated the interindividual variability in response to low-dose aspirin and other antiplatelet agents, particularly in patients with type 2 diabetes, essential thrombocythemia, polycythemia vera, and solid tumors. A major focus of her work is the validation of surrogate pharmacodynamic biomarkers, such as thromboxane B₂, and their application in optimizing individualized therapeutic strategies aimed at improving cardiovascular and oncological prevention.
Professor Petrucci has played a key role in several national and international multicenter clinical trials, including ASCEND, Add-Aspirin, ARES, ASTRO, and RivAsa. She has established collaborations with leading academic and clinical research institutions such as the MRC Clinical Trials Unit at UCL (London), the University of Oxford, Harvard Medical School, and Centro Cardiologico Monzino (Milan). Her scientific output includes more than 40 articles published in peer
reviewed international journals indexed in PubMed, as well as contributions to authoritative pharmacology and cardiovascular medicine textbooks.
In addition to her research activity, she has extensive teaching experience in Pharmacology across undergraduate and graduate health professions programs, the degree course in Medicine and Surgery, and several postgraduate schools of specialization. She has supervised numerous master’s theses and doctoral projects, and has participated as examiner and reviewer in national and international PhD programs.
She is a member of the Italian Society of Pharmacology, the Working Group on Thrombosis, and the Working Group on Cardiovascular Pharmacotherapy of the European Society of Cardiology. Her scientific contributions have been recognized with several awards for high-quality publications and research excellence.
Her academic profile is distinguished by a translational approach, integrating basic science with clinical research and therapeutic applications. Her work aims to bridge the gap between laboratory findings and clinical practice, with the ultimate goal of reducing variability in antiplatelet drug responsiveness and improving strategies for the prevention and treatment of cardiovascular and oncological diseases.